— Know what they know.
Not Investment Advice

TECH NASDAQ

Bio-Techne Corporation
1W: +0.3% 1M: +0.1% 3M: +0.9% YTD: +22.0% 1Y: +10.2% 3Y: +15.8% 5Y: -40.7%
$72.60
-0.09 (-0.12%)
After Hours: $72.75 (+0.15, +0.21%)
Weekly Expected Move ±0.3%
$72 $72 $73 $73 $73
NASDAQ · Healthcare · Biotechnology · Tech Score Buy · Power 64 · $11.4B mcap · 156M float · 2.71% daily turnover · Short 51% of daily vol
Credit Risk of going bust: lower than 84% of companies Debt: 2.5% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the safest four tenths, about 1 in 3,500 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.12 (down 99.8%), Bio-Techne Corporation would be worth roughly what it owes.
Total debt $289.1M against a stock market value of $11.40B.
Distance to default 10.93 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $100.0M (short-term plus half of long-term), stock volatility 43.3%; Altman Z'' 8.18. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.

Balance Sheet Trends

Total Assets
$2.7B +4.7% ▲
5Y CAGR: +3.4%
Total Liabilities
$571M -10.7% ▼
5Y CAGR: -3.8%
Shareholders Equity
$2.1B +9.9% ▲
5Y CAGR: +6.2%
Cash & Investments
$265M +63.2% ▲
5Y CAGR: +2.7%
Total Debt
$289M -34.9% ▼
5Y CAGR: -7.2%
Net Debt
$24M -91.4% ▼

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2022FY2023FY2024FY2025FY2026
— Assets —
Cash$173M$181M$152M$162M$265M
Short-Term Investments$74M$24M$1M$0$0
Cash & ST Investments$247M$204M$153M$162M$265M
Net Receivables$195M$218M$241M$207M$220M
Inventory$141M$172M$180M$189M$196M
Other Current Assets$23M$27M$43M$50M$63M
Total Current Assets$606M$621M$617M$608M$744M
Property, Plant & Equip.$289M$325M$342M$319M$299M
Goodwill & Intangibles$1.4B$1.4B$1.5B$1.3B$1.3B
Long-Term Investments$0$256M$242M$251M$253M
Other Non-Current Assets$47M$29M$22M$23M$11M
Total Non-Current Assets$1.7B$2.0B$2.1B$1.9B$1.9B
Total Assets$2.3B$2.6B$2.7B$2.6B$2.7B
— Liabilities —
Accounts Payable$34M$26M$38M$25M$27M
Short-Term Debt$12M$0$0$0$15M
Deferred Revenue$23M$23M$28M$33M$36M
Other Current Liabilities$1M$1M$2M$2M$24M
Total Current Liabilities$176M$129M$159M$176M$164M
Long-Term Debt$243M$350M$319M$346M$200M
Other Non-Current Liab.$17M$11M$13M$27M$19M
Total Non-Current Liabilities$418M$544M$476M$463M$407M
Total Liabilities$594M$672M$635M$639M$571M
— Equity —
Common Stock$2M$2M$2M$2M$2M
Retained Earnings$1.1B$1.3B$1.3B$1.1B$1.1B
Accumulated OCI-$75M-$66M-$78M-$60M-$71M
Total Stockholders Equity$1.7B$2.0B$2.1B$1.9B$2.1B
Total Liabilities & Equity$2.3B$2.6B$2.7B$2.6B$2.7B
— Key Metrics —
Total Debt$326M$455M$420M$444M$289M
Net Debt$153M$274M$268M$282M$24M
Total Investments$74M$280M$243M$251M$253M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms